NCT00059787 2015-12-01Erlotinib Plus Carboplatin and Paclitaxel in Ovarian CarcinomaNational Cancer Institute (NCI)Phase 2 Completed56 enrolled 10 charts
NCT00217529 2010-09-21Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube CancerFred Hutchinson Cancer CenterPhase 1/2 Completed